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Background
Bone demineralization is an emergent problem in HIV-1
infected patients for which the mechanism is multifacto-
rial. This increase raises the necessity of identifying the
predisposing factors in order to provide strategies of treat-
ment and prevention.
Methods
This is a cross-sectional study to evaluate the bone mineral
density (BMD) in HIV-infected patients from a HIV unit
of a Spanish university hospital. All patients with at least
one evaluation of BMD of total body, lumbar spine and
femoral neck measured by dual-energy X-ray absorptiom-
etry (DEXA) were included in the analysis. The Mann-
Whitney U test was used to compare two populations
(normal and abnormal bone mineralization), and the
Kruskal Wallis test to compare normal, osteopenia and
osteoporosis populations (based on the World Health
Organization criteria). A uni- and multivariant logistic
regression were used to analyse the association between
HIV disease status, demographics and antiretroviral treat-
ments with the frequency of bone abnormalities.
Summary of results
A total of 676 subjects were analysed. Median age was 45
years (interquartile range, IQR: 40–49); 72% were male;
median (IQR) time with HIV infection was 14 years (9;
17); 15% patients had reached AIDS; 95% were treated
with HAART. Patients were on antiretroviral therapy a
median of 8 years (IQR: 4.4; 11.2). Prevalence of osteope-
nia/osteoporosis was in 76% of the patients; 25% had
osteoporosis (75% male). Overall, subjects with bone
abnormalities exhibited less CD4 lymphocyte count
nadir, low body mass index (BMI), older age, and more
time on HAART (Kruskal Wallis test, p < 0.001). All
parameters that showed relation with bone abnormalities
in the univariant analysis (older age, being male, low CD4
count nadir, time on antiretroviral treatment, use of and
time on PIs regimens, exposition to TDF, and low BMI)
were included in the multivariant analysis. Results of
them showed a relation between bone abnormalities and
being male (OD: 3.9, 95% CI 2.3; 6.5, p < 0.001) and BMI
<20 kg/m2 (OD: 4.25, 95% CI 1.8; 9.8, p = 0.001).
Conclusion
The results from this cross-sectional study showed a high
prevalence of osteopenia and osteoporosis in the HIV-1+
population. It was related with being male and a low BMI
in our cohort. These results demonstrate the high fre-
quency of these abnormalities and the need for an early
detection and prevention of them.
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